Literature DB >> 19169622

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

F Raudino, P Garavaglia, C Pianezzola, G Riboldazzi, S Leva, M Guidotti, G Bono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19169622     DOI： 10.1007/s10072-009-0022-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Authors:  G L Defer; H Widner; R M Marié; P Rémy; M Levivier
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

Review 2.  Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.

Authors:  Dag Nyholm
Journal:  Expert Rev Neurother       Date:  2006-10       Impact factor: 4.618

Review 3.  Duodenal levodopa infusion for the treatment of Parkinson's disease.

Authors:  Johan Samanta; Robert A Hauser
Journal:  Expert Opin Pharmacother       Date:  2007-04       Impact factor: 3.889

Review 4.  Dopamine dysregulation syndrome in Parkinson's disease.

Authors:  Andrew H Evans; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

5.  Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.

Authors:  A Antonini; F Mancini; M Canesi; R Zangaglia; I U Isaias; L Manfredi; C Pacchetti; M Zibetti; F Natuzzi; L Lopiano; G Nappi; G Pezzoli
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977
  5 in total
  4 in total

1.  PINK1: pumps, paraesthesia, punding and psychosis.

Authors:  Dominic C Paviour; Marie-Helene Marion
Journal:  J Neurol       Date:  2011-11-30       Impact factor: 4.849

2.  Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.

Authors:  A Antonini; P Odin; L Opiano; V Tomantschger; C Pacchetti; B Pickut; U E Gasser; D Calandrella; F Mancini; M Zibetti; B Minafra; I Bertaina; P De Deyn; C Cras; E Wolf; S Spielberger; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-04-18       Impact factor: 3.575

Review 3.  Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Authors:  Maria José Catalán; Angelo Antonini; Matilde Calopa; Ovidiu Băjenaru; Oriol de Fábregues; Adolfo Mínguez-Castellanos; Per Odin; José Manuel García-Moreno; Stephen W Pedersen; Zvezdan Pirtošek; Jaime Kulisevsky
Journal:  eNeurologicalSci       Date:  2017-07-02

4.  Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.

Authors:  Oriol De Fabregues; Joan Dot; Monder Abu-Suboh; Jorge Hernández-Vara; Alex Ferré; Odile Romero; Marta Ibarria; José Luis Seoane; Nuria Raguer; Carolina Puiggros; Maria Rosa Gómez; Manuel Quintana; Josep Ramon Armengol; José Alvarez-Sabín
Journal:  Brain Behav       Date:  2017-07-07       Impact factor: 2.708
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.